semaglutide cloudy Compounded Color & Appearance Is Semaglutide Supposed to Be

Considerations for Anyone Evaluating GLP-1 Telehealth Access: Compounded medications are not FDA-approved: Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed

7 Subcutaneous semaglutide was approved in 2021 and 2022 as Wegovy for weight loss in patients 12 and older after the STEP1 trial showed patients who took subcutaneous semaglutide had a -14.9% body weight reduction (-15.3kg) compared to -2.4% (-2.6kg) with placebo after 68 weeks

Peptide therapy should always be administered: Under qualified medical supervision With appropriate laboratory monitoring Using pharmaceutical-grade products As part of a comprehensive longevity strategy Peptides are not a substitute for: Exercise Proper nutrition Stress management Sleep optimization Healthy lifestyle habits These remain the foundation of healthy aging

The driver is fat loss, not the drug acting on the testes

P.Wewer AlbrechtsenN